Welcome to Skilled in the Art. I’m Law.com IP reporter Scott Graham. If imitation is the sincerest form of flattery, then the drug-pricing antitrust class action against Gilead Sciences must look like a winner. Today I have news of the first (that I know of) copycat class action on the heels of last week’s Staley v. Gilead Sciences Inc.bombshell. Plus, check out who’s plugging (sort of) Simon Tam’s insider account of his Supreme Court battle with the PTO. And the champagne corks should be popping tomorrow in Waco as TC Heartland marks its two-year anniversary. Do not miss: Late last night, Judge Koh handed a sweeping win to the Federal Trade Commission in its antitrust battle with Qualcomm. As always, you can email meyour thoughts and follow me on Twitter.
